CRC said in a news release Monday Aera's assets represent an exceptional fit and that the companies' combination "demonstrates the merits of consolidation and reinforces CRC as a different kind of ...

Terminal ileum resection was associated with an elevated risk of developing colorectal cancer in patients with Crohn's disease regardless of sex or prior biologic therapy.